Daniel Gutmann is an associate in the Bay Area offices of Latham & Watkins.

Daniel represents private equity investors, corporate clients and other financial investors across a wide range of industries, including technology and software, life and environmental sciences, internet and digital media, and retail and consumer products.

His experience includes domestic and crossborder transactions, including:

  • Private equity transactions
  • Mergers and acquisitions, divestments
  • Management buy-outs and management participations
  • Joint ventures
  • General corporate matters

Prior to joining Latham, he practiced as a corporate associate in other leading international law firms in Germany.

Daniel’s experience includes advising: 

  • Cinven on numerous transactions, including:
    • Its US$2.6 billion acquisition of Bayer’s environmental science business*
    • Its sale of CeramTec*
    • The IPO of its portfolio company Synlab*
  • Macquarie on its acquisition of Thyssengas*
  • Permira in its acquisition of Neuraxpharm*
  • Rivean Capital (f/k/a/ Gilde Buyout Partners) on numerous transactions, including on acquiring:
    • Dataciders*
    • Init*
  • Triton on numerous transactions, including on:
    • Acquiring SCHOCK*
    • Acquiring AVS Verkehrssicherung*
    • Add-on acquisitions and divestitures for its portfolio companies*

*Matter handled prior to joining Latham

Bar Qualification

  • California
  • Rechtsanwalt (Germany)

Education

  • LLM in International Business & Economic Law, Georgetown University Law Center, 2020
  • Second German State Exam, Higher Regional Court Frankfurt, 2017
  • First German State Exam, University of Frankfurt, 2013

Languages Spoken

  • English
  • German